Journal articleJ Clin Oncol2015
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.
- Journal
- J Clin Oncol
- Published
- 12 January 2015
- Citations
- 492
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 3
- BackgroundEvaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. NCT03267173↗
- BackgroundSafety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting NCT02004262↗
- BackgroundSafety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer NCT01417000↗